13F Pro Quality Score

63.9/100

Rank #669 of 2,879 stocksTOP 25%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

35.4/100

Profitability

71.6/100

Balance Sheet

65.3/100

Earnings Quality

22.2/100

Free Cash Flow

77.6/100

Institutional Flow

65.5/100

Revenue Scale

93.9/100

Dilution Risk

52.2/100

DHR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for DANAHER CORP /DE/ (DHR), a Technology sector company. 13F Pro's AI-powered ranking engine scores DHR at 63.9/100 on a 32-signal composite quality model, placing it at rank #669 of 2,879 stocks — the top 25% of the AI-ranked universe. DHR scores in the top quartile across revenue scale (93.9), free cash flow (77.6). Areas of concern include earnings quality (22.2) and revenue growth (35.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), DANAHER CORP /DE/ reports quarterly revenue of $6.0B, net income of $1.0B, an operating margin of 22.6%. Top institutional holders of DHR by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. DHR trades on the NYSE exchange and files with the SEC under CIK 313616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DHR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DANAHER CORP /DE/ directly from SEC EDGAR. DANAHER CORP /DE/'s 13F Pro composite quality score has ranged between 8 and 82 since 2021, currently 63.9 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about DANAHER CORP /DE/

Quirks, history, and lore behind DHR — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. industrial-technology conglomerate · large-cap · listed on the NYSE · incorporated in Delaware and headquartered near Washington, DC.
  • 2
    The Numbers
    Annual revenue in the range of $30 billion, built almost entirely through acquisitions — the company has swallowed well over 400 businesses since the 1980s.
  • 3
    The History
    Founded in the mid-1980s by two brothers, it transformed from a humble real-estate investment trust into a precision-instruments and diagnostics giant through relentless deal-making.
  • 4
    The Secret
    Its real competitive edge is a proprietary lean-manufacturing system — borrowed and refined from the Toyota Production System — that it installs in every company it buys to squeeze out waste and boost margins.
  • 5
    The Lore
    It spun off its slower-growth industrial businesses in 2016 as Fortive, then spun off its dental segment as Envista in 2019 — shedding units like a snake sheds skin to stay focused on higher-margin science tools.
  • 6
    The Giveaway
    Its brands include Beckman Coulter, Hach, and Cepheid — making the water you drink cleaner and the blood tests at your doctor's office more accurate, all under one DHR-tickered roof.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$6.0B

Net Income

Q1 2026

$1.0B

Free Cash Flow

Q1 2026

$1.1B

Operating Margin

Q1 2026

22.6%

ROIC

Q1 2026

1.9%

D/E Ratio

Q1 2026

0.37

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+2.8% YoY
$24.57BFY 2025
FY21 $24.80BFY22 $26.64BFY23 $23.89BFY25 $24.57B

Net Income

-24.1% YoY
$3.61BFY 2025
FY21 $6.43BFY22 $7.21BFY23 $4.76BFY25 $3.61B

Operating Income

-9.8% YoY
$4.69BFY 2025
FY21 $6.38BFY22 $7.54BFY23 $5.20BFY25 $4.69B

EPS (Diluted)

-20.8% YoY
$5.05FY 2025
FY21 $8.61FY22 $9.66FY23 $6.38FY25 $5.05

Total Assets

-1.2% YoY
$83.46BFY 2025
FY21 $83.18BFY22 $84.35BFY23 $84.49BFY25 $83.46B

Total Debt

-8.3% YoY
$18.42BFY 2025
FY21 $22.18BFY22 $20.27BFY23 $20.10BFY25 $18.42B

Op. Cash Flow

-10.4% YoY
$6.42BFY 2025
FY21 $8.36BFY22 $8.52BFY23 $7.16BFY25 $6.42B

AI Insight: DHR Financial Trends

Strong Q1 2026 profitability masks deteriorating leverage and margin softness outside seasonal peaks.

Net income recovered to $1,029M in Q1 2026 from $555M trough in Q2 2025, driven by operating income strength at $1,344M.

Operating cash flow remains resilient at $1,322M in Q1 2026, consistent with prior-year quarterly average of ~$1,400M.

Total debt rose 14.5% from $16,510M (Q4 2024) to $19,407M (Q1 2026), while leverage ratio deteriorated.

Revenue growth remains flat: Q1 2026 at $5,951M versus $5,741M in Q1 2025, suggesting demand softness outside Q4 seasonality.

Q2 2025 net income collapsed to $555M (lowest in period), signaling earnings volatility or one-time charges requiring clarification.

AI Insight: DHR Ratio Trends

Operating margin recovered to 22.6% in Q1 2026 after Q2 2025 weakness, but ROIC momentum has stalled below prior peaks.

OpMargin rebounded from 12.8% in Q2 2025 to 22.6% in Q1 2026; NPM improved to 17.3% from 9.3% in same period.

ROIC peaked at 8.6% in Q4 2024, declined to 4.3% in Q2 2025, recovered to 7.4% in Q1 2026 — below Q4 2025's 8.5%.

Leverage stable: D/E ranged 0.33–0.37 across 9 quarters; Q1 2026 at 0.37 remains manageable.

Q2 2025 marked severe profitability trough (OpMargin 12.8%, ROIC 4.3%); root cause and recurrence risk warrant disclosure review.

ROIC has not sustained above 8.5% since Q4 2025; two consecutive quarters below 8% suggests structural headwind.

Get alerted when DHR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DANAHER CORP /DE/ including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of DHR

Put DHR on your watchlist

Track score changes the day DANAHER CORP /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is DHR a good stock to buy?

13F Pro's AI-powered analysis of DANAHER CORP /DE/ (DHR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DHR are available on the DHR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own DHR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DHR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DANAHER CORP /DE/'s investment landscape.